CNS & Neurological Disorders - Drug Targets
Formerly: Current Drug Targets - CNS & Neurological Disorders
Volume 18, 10 Issues, 2019
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access
Ranking and Category
-
150th of 267 in
Neurosciences
-
119th of 267 in
Pharmacology & Pharmacy
Contents
CNS & Neurological Disorders - Drug Targets , Volume 7 - Number 4
Drugs Used to Treat Parkinsons Disease, Present Status and Future Directions
, 7(4): 321 - 342Omar M.E. Abdel-Salam
DOI: 10.2174/187152708786441867
Seizures and Sodium Hydrogen Exchangers: Potential of Sodium Hydrogen Exchanger Inhibitors as Novel Anticonvulsants
, 7(4): 343 - 347A. Ali, F. J. Ahmad, Y. Dua, K. K. Pillai and D. Vohora
DOI: 10.2174/187152708786441830
Focus on the Role of Glutamate in the Pathology of the Peripheral Nervous System
, 7(4): 348 - 360Valentina Carozzi, Paola Marmiroli and Guido Cavaletti
DOI: 10.2174/187152708786441876
Adult Stem Cell Therapy for Acute Brain Injury in Children
, 7(4): 361 - 369James E. Carroll and Cesar V. Borlongan
DOI: 10.2174/187152708786441812
Clinical Potential of Minocycline for Schizophrenia
, 7(4): 376 - 381Tsuyoshi Miyaoka
DOI: 10.2174/187152708786441858
Brain Adaptation to Stressful Stimuli: A New Perspective on Potential Therapeutic Approaches Based on BDNF and NMDA Receptors
, 7(4): 382 - 390Ann M. Marini, Margherita Popolo, Hongna Pan, Nicolas Blondeau and Robert H. Lipsky
DOI: 10.2174/187152708786441849
  |
Editor-in-Chief
Cesar V. Borlongan
Department of Neurosurgery and Brain Repair
University of South Florida Morsani College of Medicine
Tampa, FL
USA
Biography
View Full Editorial Board
Department of Neurosurgery and Brain Repair
University of South Florida Morsani College of Medicine
Tampa, FL
USA
Biography
Biography of Cesar V. Borlongan
CESAR V. BORLONGAN, Distinguished Professor, Vice-Chairman for Research, and Director of USF Morsani College of Medicine’s Center of Excellence for Aging and Brain Repair. His highly innovative translational “bench to clinic” research has led to FDA-approved clinical trials of cell transplantation in CNS disorders. He is an author of >370 peer-reviewed publications. He is funded by and a regular reviewer for NIH, DOD, and VA. He was the President-Elect of American Society for Neural Therapy and Repair, and International Placenta Stem Cell Society, and is an elected Fellow of AAAS and AIMBE. He was featured in The Lancet in 2008.
About the Journal
For Authors
For Librarians & Readers
Journal History
Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.
Webmaster Contact: info@benthamscience.net